ACAZEN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ACAZEN Trademark

Serial Number: 79275472 • Registration: 6253453

ACAZEN is a trademark filed by Alpinia Institute for Life Sciences AG on November 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Alpinia Institute for Life Sciences AG (9 trademarks)

Bahnhofstrasse 34

Entity Type: 98

Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG (7 trademarks)

Bahnhofstrasse 34
CH-8880 Walenstadt , CH

Entity Type: 99

Trademark Details

Filing Date

November 21, 2019

Registration Date

January 26, 2021

Published for Opposition

November 10, 2020

Goods & Services

Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 26, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 7, 2021 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 15, 2021 ADCH
GENERIC MADRID TRANSACTION SENT TO IB
Apr 30, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 29, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 26, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Nov 8, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 21, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 21, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 6, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 6, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 6, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 6, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 10, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 14, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2020 REPR